Comparing treatment outcomes of stage IIIB cervical cancer patients between those with and without lower third of vaginal invasion

다국어 초록 (Multilingual Abstract)

Objective: To evaluate treatment outcomes between stage IIIB cervical cancer with and without lower third of vaginal invasion (LTI) in terms of response to treatment and overall survival (OS).
Methods: Matching one patient with LTI for 2 patients without LTI who had completed treatment between 1995 and 2012 were conducted by using treatment modalities (radiation therapy [RT] alone vs. concurrent chemoradiation therapy [CCRT]) and tumor histology (squamous cell carcinoma [SCC] vs. adenocarcinoma [ADC]). Treatment outcomes including complete response (CR) rate of RT/CCRT, patterns of treatment failure and survival outcomes were analyzed.
Results: Of 216 stage IIIB cervical cancer patients, 114 of them had no LTI and 72 had LTI. Most of the patients (83.8%) had tumor histology as SCC. The CR rates between stage IIIB without LTI and with LTI were 93.8% and 81.9% (p=0.009), and corresponding with disease progression at pelvis accounted for 18.2% and 34.4% (p=0.017), respectively. Distant metastasis was comparable between 2 groups of patients, 28.9% in patients without LTI and 29.5% in patients with LTI (p=0.988). The 2-year and 5-year OS of stage IIIB without LTI were 66.5% and 46.8% compared to stage IIIB with LTI which were 43.1% and 28.9% (p=0.004), respectively. For multivariable analysis, stage IIIB with LTI were only the influential factor on OS with hazard ratio (HR) of 1.63 (p=0.012).
Conclusion: Stage IIIB cervical cancer patients with LTI have poorer treatment outcomes including response to treatment and survival outcomes than patients in the same stage without LTI.

참고문헌 (Reference)

1 Hong JH, "The prognostic significance of pre- and posttreatment SCC levels in patients with squamous cell carcinoma of the cervix treated by radiotherapy" 41 : 823-830, 1998

2 Coia L, "The patterns of care outcome study for cancer of the uterine cervix. Results of the second national practice survey" 66 : 2451-2456, 1990

3 Cardinale JG, "Stage IIIA carcinoma of the uterine cervix" 23 : 199-204, 1986

4 Pecorelli S, "Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium" 105 : 103-104, 2009

5 Mahantshetty U, "Reporting and validation of gynaecological Groupe Euopeen de Curietherapie European Society for Therapeutic Radiology and Oncology (ESTRO) brachytherapy recommendations for MR image-based dose volume parameters and clinical outcome with high dose-rate brachytherapy in cervical cancers: a single-institution initial experience" 21 : 1110-1116, 2011

6 Horiot JC, "Radiotherapy alone in carcinoma of the intact uterine cervix according to G. H. Fletcher guidelines: a French cooperative study of 1383 cases" 14 : 605-611, 1988

7 Perez CA, "Radiation therapy alone in the treatment of carcinoma of the uterine cervix: a 20-year experience" 23 : 127-140, 1986

8 Perez CA, "Perez and Brady's principles and practice of radiation oncology" Lippincott Williams&Wilkins 1532-1609, 2008

9 Rose PG, "Nomograms predicting progression-free survival, overall survival, and pelvic recurrence in locally advanced cervical cancer developed from an analysis of identifiable prognostic factors in patients from NRG Oncology/Gynecologic Oncology Group Randomized Trials of Chemoradiotherapy" 33 : 2136-2142, 2015

10 Lee HJ, "Long-term outcomes of concomitant chemoradiotherapy incorporating high-dose-rate brachytherapy to treat locally advanced cervical cancer" 98 : 615-621, 2012

11 Rose PG, "Impact of hydronephrosis on outcome of stage IIIB cervical cancer patients with disease limited to the pelvis, treated with radiation and concurrent chemotherapy: a Gynecologic Oncology Group study" 117 : 270-275, 2010

12 Pradhan TS, "Hydronephrosis as a prognostic indicator of survival in advanced cervix cancer" 21 : 1091-1096, 2011

13 Kagei K, "High-dose-rate intracavitary irradiation using linear source arrangement for stage II and III squamous cell carcinoma of the uterine cervix" 47 : 207-213, 1998

14 Kavadi VS, "FIGO stage IIIA carcinoma of the uterine cervix" 24 : 211-215, 1992

15 Katanyoo K, "Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma in locally advanced cervical cancer" 125 : 292-296, 2012

16 Viswanathan AN, "Clinical radiation oncology" Elsevier 1173-1202, 2016

17 Pötter R, "Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer" 100 : 116-123, 2011

18 Hiilesmaa VK, "Carcinoma of the uterine cervix stage III: a report of 311 cases" 12 : 99-106, 1981

19 Montana GS, "Carcinoma of the cervix, stage III. Results of radiation therapy" 57 : 148-154, 1986

20 Stehman FB, "Carcinoma of the cervix treated with radiation therapy. I. A multi-variate analysis of prognostic variables in the Gynecologic Oncology Group." 67 : 2776-2785, 1991